HEADER VIRAL PROTEIN 11-AUG-23 7GKI TITLE GROUP DEPOSITION SARS-COV-2 MAIN PROTEASE IN COMPLEX WITH INHIBITORS TITLE 2 FROM THE COVID MOONSHOT -- CRYSTAL STRUCTURE OF SARS-COV-2 MAIN TITLE 3 PROTEASE IN COMPLEX WITH RUB-POS-1325A9EA-4 (MPRO-P0887) COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP, MAIN PROTEASE, MPRO, NON-STRUCTURAL PROTEIN COMPND 5 5, NSP5, SARS CORONAVIRUS MAIN PROTEINASE; COMPND 6 EC: 3.4.22.69; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 GENE: REP, 1A-1B; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS DIAMOND LIGHT SOURCE, I04-1, COVID MOONSHOT, CMD, MPRO, FRAGMENT KEYWDS 2 SCREENING, PANDDA, XCHEMEXPLORER, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR D.FEARON,A.AIMON,J.C.ASCHENBRENNER,B.H.BALCOMB,F.K.R.BERTRAM, AUTHOR 2 J.BRANDAO-NETO,A.DIAS,A.DOUANGAMATH,L.DUNNETT,A.S.GODOY,T.J.GORRIE- AUTHOR 3 STONE,L.KOEKEMOER,T.KROJER,R.M.LITHGO,P.LUKACIK,P.G.MARPLES, AUTHOR 4 H.MIKOLAJEK,E.NELSON,C.D.OWEN,A.J.POWELL,V.L.RANGEL,R.SKYNER, AUTHOR 5 C.M.STRAIN-DAMERELL,W.THOMPSON,C.W.E.TOMLINSON,C.WILD,M.A.WALSH, AUTHOR 6 F.VON DELFT REVDAT 2 06-DEC-23 7GKI 1 JRNL REMARK REVDAT 1 08-NOV-23 7GKI 0 JRNL AUTH M.L.BOBY,D.FEARON,M.FERLA,M.FILEP,L.KOEKEMOER,M.C.ROBINSON, JRNL AUTH 2 J.D.CHODERA,A.A.LEE,N.LONDON,A.VON DELFT,F.VON DELFT, JRNL AUTH 3 H.ACHDOUT,A.AIMON,D.S.ALONZI,R.ARBON,J.C.ASCHENBRENNER, JRNL AUTH 4 B.H.BALCOMB,E.BAR-DAVID,H.BARR,A.BEN-SHMUEL,J.BENNETT, JRNL AUTH 5 V.A.BILENKO,B.BORDEN,P.BOULET,G.R.BOWMAN,L.BREWITZ,J.BRUN, JRNL AUTH 6 S.BVNBS,M.CALMIANO,A.CARBERY,D.W.CARNEY,E.CATTERMOLE, JRNL AUTH 7 E.CHANG,E.CHERNYSHENKO,A.CLYDE,J.E.COFFLAND,G.COHEN, JRNL AUTH 8 J.C.COLE,A.CONTINI,L.COX,T.I.CROLL,M.CVITKOVIC,S.DE JONGHE, JRNL AUTH 9 A.DIAS,K.DONCKERS,D.L.DOTSON,A.DOUANGAMATH,S.DUBERSTEIN, JRNL AUTH10 T.DUDGEON,L.E.DUNNETT,P.EASTMAN,N.EREZ,C.J.EYERMANN, JRNL AUTH11 M.FAIRHEAD,G.FATE,O.FEDOROV,R.S.FERNANDES,L.FERRINS, JRNL AUTH12 R.FOSTER,H.FOSTER,L.FRAISSE,R.GABIZON,A.GARCIA-SASTRE, JRNL AUTH13 V.O.GAWRILJUK,P.GEHRTZ,C.GILEADI,C.GIROUD,W.G.GLASS, JRNL AUTH14 R.C.GLEN,I.GLINERT,A.S.GODOY,M.GORICHKO,T.GORRIE-STONE, JRNL AUTH15 E.J.GRIFFEN,A.HANEEF,S.HASSELL HART,J.HEER,M.HENRY,M.HILL, JRNL AUTH16 S.HORRELL,Q.Y.J.HUANG,V.D.HULIAK,M.F.D.HURLEY,T.ISRAELY, JRNL AUTH17 A.JAJACK,J.JANSEN,E.JNOFF,D.JOCHMANS,T.JOHN,B.KAMINOW, JRNL AUTH18 L.KANG,A.L.KANTSADI,P.W.KENNY,J.L.KIAPPES,S.O.KINAKH, JRNL AUTH19 B.KOVAR,T.KROJER,V.N.T.LA,S.LAGHNIMI-HAHN,B.A.LEFKER,H.LEVY, JRNL AUTH20 R.M.LITHGO,I.G.LOGVINENKO,P.LUKACIK,H.B.MACDONALD, JRNL AUTH21 E.M.MACLEAN,L.L.MAKOWER,T.R.MALLA,P.G.MARPLES,T.MATVIIUK, JRNL AUTH22 W.MCCORKINDALE,B.L.MCGOVERN,S.MELAMED,K.P.MELNYKOV, JRNL AUTH23 O.MICHURIN,P.MIESEN,H.MIKOLAJEK,B.F.MILNE,D.MINH,A.MORRIS, JRNL AUTH24 G.M.MORRIS,M.J.MORWITZER,D.MOUSTAKAS,C.E.MOWBRAY, JRNL AUTH25 A.M.NAKAMURA,J.B.NETO,J.NEYTS,L.NGUYEN,G.D.NOSKE, JRNL AUTH26 V.OLEINIKOVAS,G.OLIVA,G.J.OVERHEUL,C.D.OWEN,R.PAI,J.PAN, JRNL AUTH27 N.PARAN,A.M.PAYNE,B.PERRY,M.PINGLE,J.PINJARI,B.POLITI, JRNL AUTH28 A.POWELL,V.PSENAK,I.PULIDO,R.PUNI,V.L.RANGEL,R.N.REDDI, JRNL AUTH29 P.REES,S.P.REID,L.REID,E.RESNICK,E.G.RIPKA,R.P.ROBINSON, JRNL AUTH30 J.RODRIGUEZ-GUERRA,R.ROSALES,D.A.RUFA,K.SAAR,K.S.SAIKATENDU, JRNL AUTH31 E.SALAH,D.SCHALLER,J.SCHEEN,C.A.SCHIFFER,C.J.SCHOFIELD, JRNL AUTH32 M.SHAFEEV,A.SHAIKH,A.M.SHAQRA,J.SHI,K.SHURRUSH,S.SINGH, JRNL AUTH33 A.SITTNER,P.SJO,R.SKYNER,A.SMALLEY,B.SMEETS,M.D.SMILOVA, JRNL AUTH34 L.J.SOLMESKY,J.SPENCER,C.STRAIN-DAMERELL,V.SWAMY,H.TAMIR, JRNL AUTH35 J.C.TAYLOR,R.E.TENNANT,W.THOMPSON,A.THOMPSON,S.TOMASIO, JRNL AUTH36 C.W.E.TOMLINSON,I.S.TSURUPA,A.TUMBER,I.VAKONAKIS, JRNL AUTH37 R.P.VAN RIJ,L.VANGEEL,F.S.VARGHESE,M.VASCHETTO,E.B.VITNER, JRNL AUTH38 V.VOELZ,A.VOLKAMER,M.A.WALSH,W.WARD,C.WEATHERALL,S.WEISS, JRNL AUTH39 K.M.WHITE,C.F.WILD,K.D.WITT,M.WITTMANN,N.WRIGHT, JRNL AUTH40 Y.YAHALOM-RONEN,N.K.YILMAZ,D.ZAIDMANN,I.ZHANG,H.ZIDANE, JRNL AUTH41 N.ZITZMANN,S.N.ZVORNICANIN JRNL TITL OPEN SCIENCE DISCOVERY OF POTENT NONCOVALENT SARS-COV-2 MAIN JRNL TITL 2 PROTEASE INHIBITORS. JRNL REF SCIENCE V. 382 O7201 2023 JRNL REFN ESSN 1095-9203 JRNL PMID 37943932 JRNL DOI 10.1126/SCIENCE.ABO7201 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.10.4 (20-APR-2021) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.40 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 3 NUMBER OF REFLECTIONS : 46565 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.249 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.291 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.730 REMARK 3 FREE R VALUE TEST SET COUNT : 2202 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.02 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 75.54 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 932 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.4364 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 902 REMARK 3 BIN R VALUE (WORKING SET) : 0.4379 REMARK 3 BIN FREE R VALUE : 0.3909 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.22 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 30 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4637 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 334 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.59160 REMARK 3 B22 (A**2) : 0.58750 REMARK 3 B33 (A**2) : -4.17910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.226 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.195 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.215 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.191 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.930 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.896 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4789 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6498 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1596 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 837 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4789 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 616 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4573 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.01 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.55 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.57 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|* } REMARK 3 ORIGIN FOR THE GROUP (A): -8.4549 -6.3317 27.2533 REMARK 3 T TENSOR REMARK 3 T11: -0.1634 T22: 0.3082 REMARK 3 T33: -0.1464 T12: -0.0302 REMARK 3 T13: 0.0059 T23: 0.0109 REMARK 3 L TENSOR REMARK 3 L11: 2.5979 L22: 0.1235 REMARK 3 L33: 0.8945 L12: 0.2249 REMARK 3 L13: 0.5549 L23: 0.0833 REMARK 3 S TENSOR REMARK 3 S11: 0.0141 S12: -0.0198 S13: 0.0356 REMARK 3 S21: 0.0415 S22: -0.0348 S23: -0.0372 REMARK 3 S31: 0.0496 S32: -0.1468 S33: 0.0207 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: { B|* } REMARK 3 ORIGIN FOR THE GROUP (A): 3.7920 1.5252 5.8276 REMARK 3 T TENSOR REMARK 3 T11: -0.1231 T22: 0.2468 REMARK 3 T33: -0.0984 T12: 0.0129 REMARK 3 T13: 0.0195 T23: 0.0097 REMARK 3 L TENSOR REMARK 3 L11: 0.2496 L22: 1.2334 REMARK 3 L33: 2.3597 L12: 0.1429 REMARK 3 L13: -0.2010 L23: 1.5083 REMARK 3 S TENSOR REMARK 3 S11: -0.0346 S12: 0.0677 S13: -0.0210 REMARK 3 S21: -0.0021 S22: 0.0197 S23: -0.0773 REMARK 3 S31: -0.0131 S32: 0.0261 S33: 0.0149 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7GKI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-AUG-23. REMARK 100 THE DEPOSITION ID IS D_1001406296. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I04-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.91199 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36424 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.964 REMARK 200 RESOLUTION RANGE LOW (A) : 56.395 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 72.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : 0.26400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.96 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 6.30 REMARK 200 R MERGE FOR SHELL (I) : 1.23200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.54 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 15% PEG 4K, 5% DMSO, 0.1M MES PH 6.5, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.64600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.68550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 49.46700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.68550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.64600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 49.46700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3080 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26450 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 -49.46700 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 51.68550 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 THR B 45 REMARK 465 SER B 46 REMARK 465 GLU B 47 REMARK 465 ASP B 48 REMARK 465 MET B 49 REMARK 465 LEU B 50 REMARK 465 ASN B 51 REMARK 465 GLN B 306 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 33 -130.97 57.57 REMARK 500 SER A 46 -28.89 67.67 REMARK 500 ASN A 84 -121.97 62.85 REMARK 500 TYR A 154 -124.29 73.92 REMARK 500 PRO A 184 39.73 -86.53 REMARK 500 ASP B 33 -131.02 57.11 REMARK 500 ASN B 84 -123.46 62.75 REMARK 500 TYR B 154 -99.13 64.56 REMARK 500 PRO B 184 42.47 -87.12 REMARK 500 CYS B 300 32.36 -98.91 REMARK 500 SER B 301 -29.10 -149.69 REMARK 500 REMARK 500 REMARK: NULL DBREF 7GKI A 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 DBREF 7GKI B 1 306 UNP P0DTD1 R1AB_SARS2 3264 3569 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 A 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 B 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO SEQRES 4 B 306 ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO SEQRES 5 B 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN SEQRES 6 B 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 306 GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL SEQRES 8 B 306 ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 306 ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR SEQRES 15 B 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 306 THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU SEQRES 17 B 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 306 VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN SEQRES 22 B 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 306 CYS SER GLY VAL THR PHE GLN HET DMS A 401 4 HET DMS A 402 4 HET DMS A 403 4 HET DMS A 404 4 HET DMS A 405 4 HET CL A 406 1 HET QX9 A 407 22 HET DMS B 401 4 HET DMS B 402 4 HET DMS B 403 4 HETNAM DMS DIMETHYL SULFOXIDE HETNAM CL CHLORIDE ION HETNAM QX9 2-(3-CHLOROPHENYL)-N-(6-METHYLISOQUINOLIN-4-YL) HETNAM 2 QX9 ACETAMIDE FORMUL 3 DMS 8(C2 H6 O S) FORMUL 8 CL CL 1- FORMUL 9 QX9 C18 H15 CL N2 O FORMUL 13 HOH *334(H2 O) HELIX 1 AA1 SER A 10 GLY A 15 1 6 HELIX 2 AA2 HIS A 41 CYS A 44 5 4 HELIX 3 AA3 ASN A 53 ARG A 60 1 8 HELIX 4 AA4 SER A 62 HIS A 64 5 3 HELIX 5 AA5 ILE A 200 ASN A 214 1 15 HELIX 6 AA6 THR A 226 LYS A 236 1 11 HELIX 7 AA7 THR A 243 LEU A 250 1 8 HELIX 8 AA8 LEU A 250 GLY A 258 1 9 HELIX 9 AA9 ALA A 260 GLY A 275 1 16 HELIX 10 AB1 THR A 292 SER A 301 1 10 HELIX 11 AB2 SER B 10 GLY B 15 1 6 HELIX 12 AB3 HIS B 41 CYS B 44 5 4 HELIX 13 AB4 ASN B 53 ARG B 60 1 8 HELIX 14 AB5 SER B 62 HIS B 64 5 3 HELIX 15 AB6 ILE B 200 ASN B 214 1 15 HELIX 16 AB7 THR B 226 TYR B 237 1 12 HELIX 17 AB8 THR B 243 LEU B 250 1 8 HELIX 18 AB9 LEU B 250 GLY B 258 1 9 HELIX 19 AC1 ALA B 260 GLY B 275 1 16 HELIX 20 AC2 THR B 292 CYS B 300 1 9 SHEET 1 AA1 7 VAL A 73 LEU A 75 0 SHEET 2 AA1 7 PHE A 66 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 AA1 7 MET A 17 CYS A 22 -1 N GLN A 19 O GLN A 69 SHEET 4 AA1 7 THR A 25 LEU A 32 -1 O LEU A 27 N VAL A 20 SHEET 5 AA1 7 VAL A 35 PRO A 39 -1 O TYR A 37 N LEU A 30 SHEET 6 AA1 7 VAL A 86 VAL A 91 -1 O LEU A 89 N VAL A 36 SHEET 7 AA1 7 VAL A 77 GLN A 83 -1 N SER A 81 O LYS A 88 SHEET 1 AA2 5 LYS A 100 PHE A 103 0 SHEET 2 AA2 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA2 5 VAL A 148 ASP A 153 -1 N ASN A 151 O SER A 158 SHEET 4 AA2 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 AA2 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 AA3 3 LYS A 100 PHE A 103 0 SHEET 2 AA3 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 AA3 3 HIS A 172 THR A 175 -1 O ALA A 173 N MET A 165 SHEET 1 AA4 7 VAL B 73 LEU B 75 0 SHEET 2 AA4 7 PHE B 66 ALA B 70 -1 N ALA B 70 O VAL B 73 SHEET 3 AA4 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 AA4 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 AA4 7 VAL B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 AA4 7 VAL B 86 VAL B 91 -1 O LEU B 87 N CYS B 38 SHEET 7 AA4 7 VAL B 77 GLN B 83 -1 N SER B 81 O LYS B 88 SHEET 1 AA5 5 TYR B 101 PHE B 103 0 SHEET 2 AA5 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA5 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 AA5 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 AA5 5 SER B 121 ALA B 129 -1 O TYR B 126 N VAL B 114 SHEET 1 AA6 3 TYR B 101 PHE B 103 0 SHEET 2 AA6 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 AA6 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 CRYST1 67.292 98.934 103.371 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014861 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010108 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009674 0.00000